January 11, 2021
Article
The negative effects of the pandemic may disrupt efforts to eradicate HBV as a public health threat by 2030.
December 24, 2020
Screening for hepatitis B virus has become the norm in patients about to undergo anti-tumor-necrosis factor α therapy, but new research finds the risk of reactivation of resolved infections is low.
December 22, 2020
The study authors wrote that understanding this phenomena can lead to determining the best therapeutic strategy with DAAs for certain patients.
The investigators measured a 3.5-month period before and after a policy was implemented to preserve hospital resources.
December 21, 2020
Experts offered their advice on 2 domains, topic identification and ranking of priorities, for pediatric research realms.
December 18, 2020
Hepatitis B coinfection with COVID-19 did not increase either disease’s severity or increase duration of hospitalization, according to a small study in China.
December 17, 2020
Harvey Alter, Michael Houghton, and Charles Rice were awarded with the 2020 Nobel Prize in Physiology and Medicine.
December 15, 2020
There was not a statistically significant difference in eGFR between kidney recipients of HCV positive and negative donors.
December 11, 2020
Despite the increasing push for using HCV-positive organs to expand the donor pool, hundreds of livers allografts from donors are still not being used in transplantation.
December 10, 2020
Proactive efforts throughout the pandemic must be made to ensure this gap in primary and preventative care can be filled.
